ArticleAdvanced materials (Deerfield Beach, Fla.)2026
A 3D-Printed Scaffolded Hydrogel Microneedle Array Biosensor for Real-Time, Continuous Monitoring.
Article in Advanced materials (Deerfield Beach, Fla.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
Abstract
Hydrogel-based biosensors offer a promising platform for designing microneedles capable of continuously tracking biomarkers in real time. However, such biosensors have been limited by the mechanical properties of hydrated hydrogels, which are generally ineffective at penetrating the skin to access interstitial fluid (ISF). As a solution, we have developed a microneedle-array biosensor (MAB) patch that enables continuous, reversible sensing by coupling fluorescent deoxyribonucleic acid (DNA) aptamer switches to a hydrated hydrogel mesh within a 3D-printed scaffold. This scaffold provides essential mechanical support for skin insertion while preserving the apatmer-hydrogel's sensing functionality in the ISF. We demonstrate this design by tuning both aptamer switch design and hydrogel mesh size to detect exogenous levels of stress hormone cortisol and the metabolite adenosine triphosphate. We subsequently incorporated our cortisol-sensing hydrogel into the MAB scaffold and coupled this system to a custom-designed portable optical detector. Following in vitro validation, we demonstrated the biocompatibility and in vivo utility of our system by conducting continuous, real-time measurements of exogenous cortisol in the ISF of live rats. These results demonstrate, for the first time, submicromolar detection using a sensor-embedded hydrogel microneedle system, highlighting the MAB platform as a versatile solution for real-time, continuous in vivo biosensing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.